Please provide your email address to receive an email when new articles are posted on . “We think that it’s important that patients are screened before initiating ART,” Sikombe said during a news ...

A new CD4 testing system, the BD FACSPresto Near Patient CD4 Counter system (BD Biosciences), enables patients to monitor their HIV/AIDS, potentially reducing the probability of transmitting the ...

Research in Mozambique has found that the introduction of rapid point-of-care CD4 testing* almost halved the number of patients who dropped out before starting antiretroviral therapy (ART), and nearly ...

February 20, 2010 (San Francisco, California) — Viral load monitoring is significantly superior to CD4 monitoring in assessing viral suppression and treatment failure for HIV patients on ...

A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found ...

A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of ...

AIDS Healthcare Foundation (AHF) supports an appeal by Médecins Sans Frontières (MSF) urging Abbott Laboratories and Becton Dickinson (BD) to continue production of point-of-care (POC) CD4 machines.

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...

People living with HIV in rural areas of Uganda need improved access to vital medical equipment to test their levels of immunity and guide antiretroviral treatment. The Ministry of Health has promised ...